Traders who purchased shares of PROCEPT BioRobotics between February 2024 and February 2026 are being urged to consult with legal experts. A new class-action lawsuit accuses the firm of manipulating sales data through an aggressive discounting strategy. The claim suggests that the company inflated handpiece unit sales by accelerating demand, which in turn weakened future performance.
According to the lawsuit, PROCEPT (NASDAQ: PRCT) falsely told investors that the balance between handpiece sales and procedures had stayed steady. The firm’s tactics are said to have driven demand to spike each quarter, making short-term numbers look better. But these actions came at the cost of long-term results. Importantly, these sales practices were not shared with shareholders, the lawsuit alleges.
The proposed class includes all individuals who bought PROCEPT stock during the specified period. Those interested in seeking a leadership role in the case have until September 22, 2026, to file a motion for lead plaintiff. Investors are being encouraged to get in touch with Kaplan Fox for details. Although becoming a lead plaintiff is not required to take part in any recovery, it could play a role in shaping the case’s strategy.
Kaplan Fox & Kilsheimer LLP has a long track record of handling major securities cases. For example, it recently secured $2.425 billion for shareholders of Bank of America in what is the largest recovery under Section 14(a) of the Securities Exchange Act. The firm is known for pursuing corporate accountability and recovering large sums for affected investors.
Over the past 50 years, it has represented thousands of clients in complex legal disputes. The firm has been recognized for its work by legal industry publications like Chambers and Partners and Lawdragon. Its leadership in landmark cases has helped define key areas of securities and corporate law.
Kaplan Fox has secured some of the biggest recoveries in securities litigation history. Notable outcomes include $800 million for pension funds in ATRS v. The firm has been instrumental in recovering over $10 billion for its clients. Its experience in representing public and institutional investors has made it a top choice for complex cases.
Potential claimants are invited to contact Kaplan Fox through email or by phone to explore their options. Contact details are available in the release. The law firm has offices in New York and Oakland, with representatives such as Pamela Mayer and Laurence King listed for follow-up. Investors are also advised to reach out with any questions about their legal rights or potential involvement.
It is important to note that contacting Kaplan Fox does not immediately establish an attorney-client relationship. The law firm also clarifies that submitting information does not mean it will retain a person as a client. This release may be considered legal advertising in some areas, and past results do not guarantee future success in similar cases.
As the case moves forward, investors are encouraged to act before the September 22, 2026, deadline. Seeking guidance now could help determine the path of the lawsuit and ensure participation in any potential outcome.